Online Courses (English)
This just in:

State PCS

Daily Updates

Science & Technology

New Brucellosis Vaccine by ICAR

  • 24 Sep 2020
  • 4 min read

Why in News

“Brucella abortus S19Δ per vaccine” is developed by the Indian Council of Agricultural Research’s -Indian Veterinary Research Institute (ICAR-IVRI) for brucellosis prevention in the dairy sector.

Key Points

  • Brucellosis: It is a bacterial disease caused by various Brucella species, which mainly infect cattle, swine, goats, sheep and dogs.
    • It is also known as Malta fever or Mediterranean fever.
    • Brucellosis is a zoonotic disease and endemic in India causing huge economic losses to dairy industry due to:
      • Infertility
      • Abortion
      • Birth of weak off springs
      • Reduced productivity
  • Old Vaccine:
    • B. abortus S19 strain: In India, calf-hood vaccination is practiced using live attenuated Brucella abortus S19 strain for control of the disease.
    • B. abortus S19 strain is a very strong immunogen and provides lifelong immunity.
      • An immunogen refers to a molecule that is capable of eliciting an immune response by an organism's immune system.
    • Drawbacks:
      • Residual virulence to humans and animals.
      • Not suitable for vaccination in adult animals.
      • Causes abortion when used in pregnant animals.
      • Interferes with sero-diagnosis of clinical infection.
  • New Vaccine: To overcome some of these drawbacks, a modified strain of B. abortus S19 has been developed at ICAR-IVRI. The newly developed strain is named as B. abortus S19Δ per.
    • It is developed under the Department of Biotechnology (DBT) funded “Brucellosis network program”.
      • The programme aims at studying the epidemiological status of Brucella infections in India and to develop novel diagnostics and vaccines.
    • In the process of modifying the S19 strain, lipopolysaccharide (LPS) structure of the organism was altered through deletion mutation.
      • Lipopolysaccharide is the major component of the outer membrane of Gram-negative bacteria.
      • A deletion mutation occurs when part of a DNA molecule is not copied during DNA replication.
    • Vaccine potential of S19Δ per has been evaluated in experimental small animal models and also in buffalo calves.
    • The vaccine has great demand in India and will be of immense help in the national control programme on brucellosis.
    • The vaccine has DIVA capability.
      • DIVA means differentiating infected from vaccinated animals. These vaccines, also termed as marker vaccines, can differentiate between naturally infected and vaccinated animals.

Infection to Humans

  • Brucellosis has infected over 3000 people in China.
  • Humans generally acquire the disease through:
    • Direct contact with infected animals or
    • Eating, drinking contaminated animal products, unpasteurized milk or
    • Inhaling airborne agents.
  • The US Centers for Disease Control and Prevention states that person-to-person transmission of brucellosis is “extremely rare” but some symptoms may reoccur or never go away.
  • Symptoms of Brucellosis include fever, sweats, malaise, anorexia (psychological disorder in which one eats less due to fear of weight gain), headache and muscle pain.
  • Treatment and prevention:
    • It is usually treated with antibiotics, including rifampin and doxycycline.
    • Avoiding unpasteurised dairy products and taking safety precautions such as wearing rubber gloves, gowns or aprons, when handling animals or working in a laboratory can help prevent or reduce the risk of getting brucellosis.
    • Other preventive measures include cooking meat properly, vaccinating domestic animals, etc.

Source PIB

SMS Alerts

Please login or register to view note list


Please login or register to list article as bookmarked


Please login or register to make your note


Please login or register to list article as progressed


Please login or register to list article as bookmarked